In-womb birth defect treatments possible

Oct 16, 2006

British-led research into cleft lip and palate might lead to babies with certain craniofacial disorders being successfully treated in the womb.

University of Manchester researchers say they have uncovered the causes behind two genetic conditions that lead to facial anomalies including clefts, where the lip and often the roof of the mouth, or palate, fail to form properly.

Working with colleagues at the University of Iowa, Manchester husband and wife team Mike and Jill Dixon and researcher Rebecca Richardson identified the role of a gene called IRF6.

The team established that mice missing the gene developed abnormal skin as well as cleft palate. Further analysis revealed IRF6 controls the development of keratinocytes -- the main type of cells in the outer layers of the skin, known as the epidermis.

"Put simply, mutations of IRF6 in Van de Woude syndrome make the skin cells too sticky, so they stick to each other and other types of cell much sooner than they should resulting in these facial anomalies," said Mike Dixon.

The findings appear in the current issue of the journal Nature Genetics.

Copyright 2006 by United Press International

Explore further: Australian treatment could save wounded soldiers

add to favorites email to friend print save as pdf

Related Stories

Scientists uncover evolutionary keys to common birth disorders

Jan 14, 2009

The work of Forsyth scientist Peter Jezewski, DDS, Ph.D., has revealed that duplication and diversification of protein regions ('modules') within ancient master control genes is key to the understanding of certain birth disorders. ...

Researchers discover gene for branchio-oculo-facial syndrome

Apr 23, 2008

Boston, MA--In a collaborative effort, researchers from Boston University School of Medicine (BUSM) have discovered that deletions or mutations within the TFAP2A gene (Activating Enhancer-Binding Protein) result in the distinctive ...

Recommended for you

A hybrid vehicle that delivers DNA

17 hours ago

A new hybrid vehicle is under development. Its performance isn't measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.